These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6794552)

  • 1. The influence of supplemental sodium acetate on carbonic anhydrase inhibitor-induced side effects.
    Arrigg CA; Epstein DL; Giovanoni R; Grant WM
    Arch Ophthalmol; 1981 Nov; 99(11):1969-72. PubMed ID: 6794552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitor side effects. Serum chemical analysis.
    Epstein DL; Grant WM
    Arch Ophthalmol; 1977 Aug; 95(8):1378-82. PubMed ID: 889513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing side effects of carbonic anhydrase inhibitors.
    Lichter PR
    Ophthalmology; 1981 Mar; 88(3):266-9. PubMed ID: 7231916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient tolerance to carbonic anhydrase inhibitors.
    Lichter PR; Newman LP; Wheeler NC; Beall OV
    Am J Ophthalmol; 1978 Apr; 85(4):495-502. PubMed ID: 655230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function.
    Cowan RA; Hartnell GG; Lowdell CP; Baird IM; Leak AM
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):347-8. PubMed ID: 6432091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased libido--a side effect of carbonic anhydrase inhibitor.
    Wallace TR; Fraunfelder FT; Petursson GJ; Epstein DL
    Ann Ophthalmol; 1979 Oct; 11(10):1563-6. PubMed ID: 555849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MK-927: a topically effective carbonic anhydrase inhibitor in patients.
    Bron AM; Lippa EA; Hofmann HM; Feicht BI; Royer JG; Brunner-Ferber FL; Panebianco DL; Von Denffer HA
    Arch Ophthalmol; 1989 Aug; 107(8):1143-6. PubMed ID: 2667509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: responses to citrate.
    Higashihara E; Nutahara K; Takeuchi T; Shoji N; Araie M; Aso Y
    J Urol; 1991 May; 145(5):942-8. PubMed ID: 2016806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy.
    Hiett JA; Dockter CA
    Optom Clin; 1992; 2(4):97-112. PubMed ID: 1286242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M; Cyrlin M; Lippa EA; Esposito D; Deasy D; Panebianco D; Fazio R; Yablonski M; Shields MB
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibition in glaucoma: hazard or benefit for the chronic lunger?
    Block ER; Rostand RA
    Surv Ophthalmol; 1978; 23(3):169-72. PubMed ID: 734612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R; Ticho U
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors.
    Kanski JJ
    Br J Ophthalmol; 1968 Aug; 52(8):642-3. PubMed ID: 5724852
    [No Abstract]   [Full Text] [Related]  

  • 14. Timolol plus maximum-tolerated antiglaucoma therapy.
    Zimmerman TJ; Gillespie JE; Kass MA; Yablonski ME; Becker B
    Arch Ophthalmol; 1979 Feb; 97(2):278-9. PubMed ID: 399180
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypercarbia and acidosis associated with carbonic anhydrase inhibition: a hazard of topical mafenide acetate use in renal failure.
    Liebman PR; Kennelly MM; Hirsch EF
    Burns Incl Therm Inj; 1982 Jul; 8(6):395-8. PubMed ID: 6809230
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
    March WF; Ochsner KI
    Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term use of carbonic anhydrase inhibitors and hematologic side effects.
    Fraunfelder FT; Fraunfelder FW
    Arch Ophthalmol; 1992 Apr; 110(4):446-7. PubMed ID: 1562240
    [No Abstract]   [Full Text] [Related]  

  • 19. [Local carbonic anhydrase inhibitors MK-927 and Mk-417. Effect and tolerance].
    Gerling J; Pfeiffer N; Lippa E; Brunner-Ferber F; Grehn F
    Fortschr Ophthalmol; 1990; 87(6):692-5. PubMed ID: 2086420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension.
    Lewis RA; Schoenwald RD; Barfknecht CF; Phelps CD
    Arch Ophthalmol; 1986 Jun; 104(6):842-4. PubMed ID: 3521557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.